<DOC>
	<DOCNO>NCT01225913</DOCNO>
	<brief_summary>The purpose study evaluate site mechanism responsible expiratory airflow limitation chronic , treat , non-smoking , stable asthmatic moderate severe persistent expiratory airflow obstruction . Treatment include inhaled corticosteroid long act beta2agonists . The investigator interested determine whether large and/or small airway predominant site airflow limitation . The investigator also interested determine whether intrinsic small airway obstruction and/or loss lung elastic recoil responsible expiratory airflow limitation . The investigator also interested evaluate role vary dos inhaled corticosteroid suppress large small airway inflammation use exhale nitric oxide surrogate marker inflammation . For comparison purpose , spirometry measurement exhale nitric oxide also obtain possible naturally occur exacerbation asthma .</brief_summary>
	<brief_title>Mechanism ( ) Airflow Limitation During Exacerbation Asthma</brief_title>
	<detailed_description>In addition also obtain study asthmatic naturally occur exacerbation asthma follow treatment . If available , result lung function study include measurement lung elastic recoil compare pathologic analysis formalin fix , air inflate lung obtain autopsy asthmatic die asthma relate non-asthma related death . This kind lung structure-function study provide potential mechanism ( ) explain loss lung elastic recoil acute chronic asthmatic non-smokers . We also obtain voxel quantification high resolution thin section CT lung obtain without IV contrast . Also , use fiberoptic bronchoscopy obtain optical coherence tomography stable asthmatic mild moderate severe expiratory airflow limitation ass integrity lung parenchyma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Current nonsmoking ( &lt; 10 pack yr smoke history ) Stable , treat asthmatic Age 1080 yr post 180ug albuterol MDI : FEV 1/FVC &lt; 70 % FEV 1 &lt; 80 % predict Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>asthma</keyword>
	<keyword>lung function</keyword>
	<keyword>inflammation</keyword>
</DOC>